Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Georgia for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Georgia only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Georgia (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

James Frank (NPI 1669436143)

Field	Value
Entity Type	Individual
Organization	James Frank
Address	3225 Cumberland Blvd Se Ste 800
City	Atlanta
State	GA
ZIP	30339
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	April 13, 2006

Payer Source	Total Paid
Medicare	$2.4M
Medicaid	$0

Key Findings

This provider’s Medicare footprint is the clear commercial axis of their billing profile: total Medicare revenue is $2.4M and there is no Medicaid billing on file, so the practice is effectively single‑payer in the public programs dataset and depends heavily on Medicare volume for its public-payer revenue. This concentration of payer exposure means state‑level Medicaid dynamics will not directly affect the reported public revenue for this NPI.

Revenue is highly concentrated in a small set of intravitreal therapy codes: the precomputed top‑3 Medicare codes account for 88.9% of the provider’s total Medicare revenue, driven by J0178 $1.7M (72.2%), J2777 $250.6K (10.6%), and 67028 $144.1K (6.1%). That degree of concentration signals that a few high‑cost drug and injection procedure codes are the dominant business lines for this clinician.

The code mix strongly indicates a medical‑retina, injection‑centric practice rather than a broad general ophthalmology or surgical retina profile: J0178 and J2777 are anti‑VEGF intravitreal drug codes and 67028 is the intravitreal injection procedure, which together point to recurring, chronic injectables management (e.g., neovascular AMD, DME) as the core service offering. This operational pattern aligns with recurring visit and imaging workflows rather than one‑time surgical cases.

Competitive standing on the top drug is high but characterized as within expected norms: J0178 ranks #326 of 3204 nationally (90th percentile; typical, unremarkable volume), so the provider is a high‑volume user of aflibercept relative to many peers but not an extreme outlier. Coupled with the $1.7M revenue on J0178, this suggests aflibercept is the dominant revenue driver for the practice’s Medicare business.

Other anti‑VEGF and injectable patterns show selective use: J2777 (faricimab) produced $250.6K and ranks #1112 of 2039 (45th percentile; typical, unremarkable volume), while J2778 (ranibizumab) and J9035 (bevacizumab) show lower and mixed standing (J2778 ranks in the 23rd percentile with $61.1K, J9035 ranks in the 71st percentile with $14K). This mix suggests a preference for aflibercept with some adoption of faricimab and continued, but smaller, use of alternative agents.

High diagnostic and follow‑up imaging volume supports the injection‑heavy care model: 92134 accounts for $66.3K and ranks #856 of 26868 (97th percentile; notably above typical national volume), and 92014 accounts for $77.9K and ranks #1996 of 35415 (94th percentile; notably above typical national volume). Elevated OCT interpretation and established‑patient comprehensive exam volumes are consistent with frequent monitoring and ongoing management of chronic retinal disease.

Procedural and ancillary services beyond injections are present but secondary: 67028 contributes $144.1K (6.1% of Medicare revenue) and ranks #569 of 4255 (87th percentile; typical, unremarkable volume), while angiography (92235) and fundus photography (92250) contribute much smaller revenue shares. This pattern reinforces a workflow focused on injection procedures with targeted use of diagnostic imaging and procedural retina interventions.

The provider has a long tenure in the Medicare dataset with NPI enumeration on 2006-04-13 (~20 years), indicating an established practice and a sustained billing history for the services observed; stability of enrollment combined with the concentrated, injection‑led revenue mix suggests an ongoing, mature medical‑retina practice rather than a newly formed or transient operation.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

18 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,490	$690	$1.7M
J2777	Injection, faricimab‑svoa, 0.1 mg	8,640	$30	$250.6K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,740	$80	$144.1K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	920	$90	$77.9K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,210	$30	$66.3K
J2778	Injection, ranibizumab, 0.1 mg	340	$180	$61.1K
92235	The provider uses a special dye, fluorescein that causes the blood vessels in the one or both eyes to stand out in photographic images taken with the use of multiframe timing, or serial images, taken…	140	$110	$14.7K
J9035	Injection, bevacizumab, 10 mg	270	$50	$14K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	100	$100	$9.4K
67210	The provider destroys a lesion of the retina using a laser beam that heats up the tissue.	20	$400	$7.7K

Showing 1–10 of 18

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 18 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Georgia Distribution

James Frank — 4 of 18 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Georgia

Full comparison — all codes billed, vs. state median

18 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	4	70	970	$680	$700.6K
J2777	31	40	14,100	$30	$524.3K
J2778	24	30	1,170	$180	$286.2K
67028	9	80	720	$90	$71.9K
92014	39	850	130	$80	$19.7K
99214	7,626	13,640	120	$80	$17.8K
67210	5	10	20	$370	$12.5K
92012	376	380	90	$60	$10.5K
J9035	18	70	120	$50	$10.3K
99213	11,147	13,360	80	$60	$9.2K

Showing 1–10 of 18

Related Providers

Other providers that share a Tax Identification Number (TIN) with James Frank, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Ryan Whitted	GA	Ophthalmology Physician	$2.5M	$0
Eye Consultants Of Atlanta Piedmont	GA	Ophthalmologic Surgery Clinic/Center	$2.3M	$0
Margaret Wong Gribble	GA	Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician	$2M	$0
Matthew Camp	GA	Ophthalmology Physician	$1.2M	$0
Nikhil Anand	GA	Ophthalmology Physician	$404.1K	$0
John Roach	GA	Ophthalmology Physician	$340.7K	$0
Elliot Levine	GA	Ophthalmology Physician	$336.3K	$0
Brian Long	GA	Ophthalmology Physician	$306.9K	$0
Scott Gardner	GA	Ophthalmology Physician	$289.2K	$0
Charles Tucker	GA	Ophthalmology Physician	$276.5K	$0

Nearby Providers

Other providers in the same ZIP code as James Frank, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
K&s Clinical Diagnostics Consulting Services, LLC	GA	Clinical Medical Laboratory	$621.2K	$229.3K
A Plus Pediatric Dentistry Of Atlanta	GA	Pediatric Dentistry	$0	$637.3K
Crestre Boddy	GA	Clinical Social Worker	$446.8K	$0
Charles Thompson	GA	Ophthalmology Physician	$405K	$23.8K
Christine Page	GA	Mental Health Counselor	$0	$424K
Care1 Sc, LLC	GA	Gerontology Nurse Practitioner	$0	$299.2K
David Vieth	GA	Dentist	$0	$267.2K
William Lee	GA	Cornea and External Diseases Specialist Physician	$241.9K	$0
Evan Loft	GA	Cornea and External Diseases Specialist Physician	$237.6K	$0
Ngoneh Gaye-bullard	GA	Social Worker	$206.7K	$0

James Frank — Billing Profile & Reimbursement Data

Sign up for James Frank — Billing Profile & Reimbursement Data policy alerts

James Frank — Billing Profile & Reimbursement Data

Sign up for James Frank — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References